Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655
- PMID: 8569699
Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655
Abstract
Benzothiadiazides such as cyclothiazide potentiate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor responses, whereas 2,3-benzodiazepines such as 1-(4-aminophenyl)-3-methylcarbamyl-4-methyl-7,8-methylenedioxy-3,4 -dihydro- 5H-2,3-benzodiazepine (GYKI 53655) act as noncompetitive antagonists; both drugs act through allosteric modulation. Controversy exists as to whether cyclothiazide and GYKI 53655 act at a common site. Recent mutational analysis has led to the identification of a serine residue in flip splice variants that is critical for directing the interaction of cyclothiazide with AMPA receptors. We tested whether the mutation of this residue to glutamine, which abolishes potentiation by cyclothiazide, can in addition block antagonism by 2,3-benzodiazepines, as would be predicted for action at a common site. We found that the S to Q mutation does not alter antagonism by 2,3-benzodiazepines, suggesting that the molecular determinants directing the interaction between GYKI 53655 and AMPA receptors are not identical to those controlling sensitivity to cyclothiazide. Additional support for this was obtained from analysis of the responses of AMPA receptor flip/flop splice variants, which, despite differences in equilibrium desensitization and sensitivity to cyclothiazide, show only small differences in sensitivity to 2,3-benzodiazepines. Furthermore, introduction of the flip exon from GluRA into GluR6, conferred sensitivity to cyclothiazide but did not increase sensitivity to 2,3-benzodiazepines. Of interest, experiments with native AMPA receptors generated from hippocampal and forebrain poly(A)+ mRNA revealed greater sensitivity to 2,3-benzodiazepines than receptors generated by expression of recombinant AMPA receptors, possibly indicating the existence of an unidentified accessory protein or novel receptor subunit.
Similar articles
-
Negative allosteric modulation of AMPA-preferring receptors by the selective isomer GYKI 53784 (LY303070), a specific non-competitive AMPA antagonist.CNS Drug Rev. 2002 Fall;8(3):235-54. doi: 10.1111/j.1527-3458.2002.tb00227.x. CNS Drug Rev. 2002. PMID: 12353057 Free PMC article. Review.
-
Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.Mol Pharmacol. 1995 Nov;48(5):946-55. Mol Pharmacol. 1995. PMID: 7476926
-
Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.Neuroscience. 1998 Dec;87(3):615-29. doi: 10.1016/s0306-4522(98)00109-2. Neuroscience. 1998. PMID: 9758228
-
Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466.Mol Pharmacol. 1996 Jan;49(1):123-31. Mol Pharmacol. 1996. PMID: 8569697
-
Non-competitive AMPA antagonists of 2,3-benzodiazepine type.Curr Pharm Des. 2002;8(10):913-39. doi: 10.2174/1381612024607081. Curr Pharm Des. 2002. PMID: 11945139 Review.
Cited by
-
Activation and desensitization of hippocampal kainate receptors.J Neurosci. 1997 Apr 15;17(8):2713-21. doi: 10.1523/JNEUROSCI.17-08-02713.1997. J Neurosci. 1997. PMID: 9092592 Free PMC article.
-
Allosteric competition and inhibition in AMPA receptors.Nat Struct Mol Biol. 2024 Nov;31(11):1669-1679. doi: 10.1038/s41594-024-01328-0. Epub 2024 Jun 4. Nat Struct Mol Biol. 2024. PMID: 38834914 Free PMC article.
-
AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate.J Neurosci. 1996 Nov 1;16(21):6634-47. doi: 10.1523/JNEUROSCI.16-21-06634.1996. J Neurosci. 1996. PMID: 8824304 Free PMC article.
-
Negative allosteric modulation of AMPA-preferring receptors by the selective isomer GYKI 53784 (LY303070), a specific non-competitive AMPA antagonist.CNS Drug Rev. 2002 Fall;8(3):235-54. doi: 10.1111/j.1527-3458.2002.tb00227.x. CNS Drug Rev. 2002. PMID: 12353057 Free PMC article. Review.
-
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.Pharmacol Rev. 2021 Oct;73(4):298-487. doi: 10.1124/pharmrev.120.000131. Pharmacol Rev. 2021. PMID: 34753794 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources